Evaluation of risk factors for chemotherapy-induced nausea and vomiting in cisplatin and gemcitabine treatment for biliary tract cancer: acid suppressants do not prevent nausea.
Sign Up to like & getrecommendations! Published in 2022 at "Die Pharmazie"
DOI: 10.1691/ph.2022.2355
Abstract: Chemotherapy-induced nausea and vomiting (CINV) is one of the most serious adverse effects of cancer therapy. Cancer patients frequently use acid suppressants (AS) for palliation of gastrointestinal symptoms associated with malignancy and/or anticancer therapy. AS… read more here.
Keywords: cisplatin gemcitabine; gemcitabine treatment; administration; nausea ... See more keywords
Endoscopic treatment of biliary complications in left lobe living donor liver transplantation
Sign Up to like & getrecommendations! Published in 2018 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s175215
Abstract: Purpose Almost all of the publications regarding the treatment of biliary complications after liver transplantation are related to biliary complications after right lobe living donor liver transplantation (LDLT) and cadaveric liver transplantation (LT). The number… read more here.
Keywords: treatment biliary; liver transplantation; left lobe; biliary complications ... See more keywords
Treatment of biliary tract carcinoma over the last 30 years.
Sign Up to like & getrecommendations! Published in 2022 at "Bioscience trends"
DOI: 10.5582/bst.2022.01267
Abstract: Surgical resection could offer the only chance of a long-term cure for biliary tract carcinoma. However, only a small percentage of these patients can undergo surgery based on the progression of the disease. Most patients… read more here.
Keywords: biliary tract; treatment biliary; tract carcinoma;